Nucala (mepolizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** MEPOLIZUMAB

**Strength:** 40 mg/.4mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** GlaxoSmithKline LLC

**Marketing category:** BLA (BLA761122)

**Pharmacologic class:** Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]